Innate Pharma S.A. (EPA:IPH)
1.810
-0.002 (-0.11%)
Apr 1, 2025, 12:32 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €151.87 million as of April 1, 2025. Its market cap has decreased by -13.43% in one year.
Market Cap
151.87M
Enterprise Value
102.09M
Revenue
20.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.81
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 151.87M, an increase of 19,072.21%. That is a compound annual growth rate of 33.01%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sanofi | 126.57B |
EssilorLuxottica Société anonyme | 121.76B |
Sartorius Stedim Biotech | 18.06B |
bioMérieux | 13.73B |
Eurofins Scientific SE | 9.39B |
Ipsen | 8.84B |
Virbac | 2.52B |
emeis Société anonyme | 1.76B |